Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mesa Laboratories (MLAB) Receivables (2016 - 2025)

Mesa Laboratories' Receivables history spans 15 years, with the latest figure at $40.2 million for Q4 2025.

  • For Q4 2025, Receivables fell 4.14% year-over-year to $40.2 million; the TTM value through Dec 2025 reached $40.2 million, down 4.14%, while the annual FY2025 figure was $42.0 million, 7.46% up from the prior year.
  • Receivables for Q4 2025 was $40.2 million at Mesa Laboratories, roughly flat from $40.1 million in the prior quarter.
  • Across five years, Receivables topped out at $42.6 million in Q1 2023 and bottomed at $20.6 million in Q2 2021.
  • The 5-year median for Receivables is $39.6 million (2025), against an average of $37.0 million.
  • The largest annual shift saw Receivables surged 103.32% in 2022 before it fell 15.03% in 2023.
  • A 5-year view of Receivables shows it stood at $37.3 million in 2021, then grew by 13.69% to $42.4 million in 2022, then fell by 15.03% to $36.0 million in 2023, then grew by 16.51% to $42.0 million in 2024, then fell by 4.14% to $40.2 million in 2025.
  • Per Business Quant, the three most recent readings for MLAB's Receivables are $40.2 million (Q4 2025), $40.1 million (Q3 2025), and $39.1 million (Q2 2025).